One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Instructions for Authors
doi : 10.1016/S2405-500X(22)01102-1
Volume 9, Issue 1, January 2023, Pages A6-A15
Retrospective Window of Interest Annotation Provides New Insights Into Functional Channels in Ventricular Tachycardia Substrate
Joshua Hawson, MBBS, a,b Ahmed Al-kaisey, MBBS, a,b Robert D. Anderson, MBBS, BS C, P HD, a,b David Chieng, MBBS,b,c Louise Segan, MBBS,b,c Troy Watts, BS C, a Timothy Campbell, BSC ,d Joseph Morton, MBBS, PH D, a Alexander McLellan, MBBS, P HD, a Paul Sparks, MBBS, PH D, a Adam Lee, MBBS, PH D, e Edward P. Gerstenfeld, MD,f Henry H. Hsia, MD, e Aleksander Voskoboinik, MBBS, PH D, b,c Sandeep Prabhu, MMBS, P HD, c Bhupesh Pathik, MBBS, PHD, a Saurabh Kumar, BS C (M ED ), MBBS, PHD, d,f Peter Kistler, MBBS, PH D, b,c Jonathan Kalman, MBBS, PHD, a,b Geoffrey Lee, MBC HB, PH D
doi : 10.1016/j.jacep.2022.10.025
Volume 9, Issue 1, January 2023, Pages 1-16
Accurate annotation of local activation time is crucial in the functional assessment of ventricular tachycardia (VT) substrate. A major limitation of modern mapping systems is the standard prospective window of interest (sWOI) is limited to 490 to 500 milliseconds, preventing annotation of very late potentials (LPs). A novel retrospective window of interest (rWOI), which allows annotation of all diastolic potentials, was used to assess the functional VT substrate.
Importance of Right Ventricular Mapping and Ablation for Ventricular Tachycardia in Postinfarction Patients
Michael Ghannam, MD, Jackson J. Liang, DO, Rakesh Latchamsetty, MD, Thomas Crawford, MD, Krit Jongnarangsin, MD, Fred Morady, MD, Frank Bogun, MD
doi : 10.1016/j.jacep.2022.08.034
Volume 9, Issue 1, January 2023, Pages 17-25
The characteristics of patients with post-myocardial infarction (PMI) ventricular tachycardia (VT) who require right ventricular (RV) ablation are underreported.
The “Other� Ventricle: The Role of RV Mapping in Postinfarction Ventricular Tachycardia∗
Nilesh Mathuria, MD
doi : 10.1016/j.jacep.2022.10.020
Volume 9, Issue 1, January 2023, Pages 26-27
Acute and Long-Term Scar Characterization of Venous Ethanol Ablation in the Left Ventricular Summit
Stephanie C. Fuentes Rojas, MD,a Maan Malahfji, MD, a Liliana Tavares, MD,a Apoor Patel, MD, a Paul A. Schurmann, MD,a Amish S. Dave, MD, PHD, a Carlos Tapias, MD,b Diego RodrÃguez, MD,b Luis Carlos Sáenz, MD,b Sergey Korolev, MD, c Giorgi Papiashvili, MD, P HD, d Petr Peichl, MD, e Josef Kautzner, MD, e Krzysztof Blaszyk, MD, PH D, f Katarzyna Malaczynska-Rajpold, MD, P HD, g Tiffany Chen, MD,h Pasquale Santangeli, MD,h Dipan J. Shah, MD, a Miguel Valderrábano, MD
doi : 10.1016/j.jacep.2022.08.035
Volume 9, Issue 1, January 2023, Pages 26-27
Venous Ethanol for Left Ventricular Summit Arrhythmia: Control of the Extent of Scar
Mikael Laredo, MD, MSC , Estelle Gandjbakhch, MD, PHD
doi : 10.1016/j.jacep.2022.10.011
Volume 9, Issue 1, January 2023, Pages 40-42
Relationship Between Periodontitis and Atrial Fibrosis in Atrial Fibrillation: Histological Evaluation of Left Atrial Appendages
Shunsuke Miyauchi, MD, PH D, a,b Hiromi Nishi, DDS, PH D, c Kazuhisa Ouhara, DDS, PHD, d Takehito Tokuyama, MD, PH D, a Yousaku Okubo, MD, PH D, a Sho Okamura, MD, PH D, a Shogo Miyamoto, MD,a Naoto Oguri, MD, a Yukimi Uotani, MD, a Taiichi Takasaki, MD, P HD, e Keijiro Katayama, MD, PHD, e Hisako Furusho, DDS, P HD, f Mutsumi Miyauchi, DDS, P HD, f Shinya Takahashi, MD, PHD, e Toru Hiyama, MD, P HD, b Yukiko Nakano, MD, P HD a
doi : 10.1016/j.jacep.2022.08.018
Volume 9, Issue 1, January 2023, Pages 43-53
Is Periodontitis a Modifiable Risk Factor for Atrial Fibrillation Substrate?∗
Andreas Goette, MD
doi : 10.1016/j.jacep.2022.09.013
Volume 9, Issue 1, January 2023, Pages 54-56
Atrial Standstill in the Pediatric Population: A Multi-Institution Collaboration
Taylor S. Howard, MD,a, * David Y. Chiang, MD, PH D, b, * Scott R. Ceresnak, MD,c Virginie Beausejour Ladouceur, MD, d Robert D. Whitehill, MD, e Richard J. Czosek, MD, f Timothy K. Knilans, MD, f Agnethe M. Ahnfeldt, MD, g Malene Lando Borresen, MD, g Edgar Jaeggi, MD,d Sharmila Udupa, MD,h Robert Gow, MBBS, h Jeremy P. Moore, MD,i,j Roberto G. Galloti, MD, k Doug Y. Mah, MD, l Jeffrey J. Kim, MD, a Santiago O. Valdes, MD, a Dianna M. Milewicz, MD, m Christina Y. Miyake, MD, MS
doi : 10.1016/j.jacep.2022.08.022
Volume 9, Issue 1, January 2023, Pages 57-69
Atrial standstill (AS) is a rare condition characterized by absence of electrical activity within the atria. Studies to date have been limited.
Time to Move Forward on Pediatric Atrial Standstill
Reina Bianca M. Tan, MD,a Therese M. Giglia, MD,b Frank Cecchin, MD a
doi : 10.1016/j.jacep.2022.11.025
Volume 9, Issue 1, January 2023, Pages 70-72
Association of Weight With Ablation Outcomes in Pediatric Wolff-Parkinson-White: Analysis of the NCDR IMPACT Registry
Christopher M. Janson, MD, CCDS, CEPS-P, a,b Maully J. Shah, MBBS, FHRS, CCDS, CEPS-P, a,b Kevin F. Kennedy, MS, c V. Ramesh Iyer, MD, MRCP, a,b Shashank Behere, MD, d Tammy L. Sweeten, MS,a,b Michael L. O’Byrne, MD, MSCE
doi : 10.1016/j.jacep.2022.08.023
Volume 9, Issue 1, January 2023, Pages 73-84
Guidelines for electrophysiology study (EPS) and catheter ablation in Wolff-Parkinson-White (WPW) are age based, but size may be a more relevant factor in determination of outcomes.
Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation—A Prospective Randomized Trial
Roman Piotrowski, MD, PH D, Jakub Baran, MD, PHD, Agnieszka Sikorska, MD, P HD, Tomasz Krynski, MD, Piotr Kulakowski, MD, PH D
doi : 10.1016/j.jacep.2022.08.011
Volume 9, Issue 1, January 2023, Pages 85-95
Treatment of cardioinhibitory vasovagal syncope (VVS) is difficult. Recently, cardioneuroablation (CNA) has emerged as a new therapeutic option.
Incidence, Predictors, and Clinical Outcomes of Device-Related Thrombus in the Amulet IDE Trial
Boris Schmidt, MD,a Jens Erik Nielsen-Kudsk, MD, DMS C,b Christopher R. Ellis, MD,c David Thaler, MD, P HD, d Sajjad A. Sabir, MD, e Alok Gambhir, MD, PHD, f Ulf Landmesser, MD,g Neeraj Shah, MD,h William Gray, MD, i Vijendra Swarup, MD,j D. Scott Lim, MD, k Konstantinos Koulogiannis, MD, l Jordan A. Anderson, PHD, m Ryan Gage, MS,m Dhanunjaya Lakkireddy, MD n
doi : 10.1016/j.jacep.2022.07.014
Volume 9, Issue 1, January 2023, Pages 96-107
Device-related thrombus (DRT) following left atrial appendage occlusion (LAAO) can lead to adverse clinical outcomes. DRT rates and outcomes from randomized trials are limited.
Device-Related Thrombus After Left Atrial Appendage Occlusion: The Villain of the Piece∗
Daniel J. Friedman, MD, a,b Jonathan P. Piccini, MD, MHS
doi : 10.1016/j.jacep.2022.11.029
Volume 9, Issue 1, January 2023, Pages 108-110
Isoproterenol-Assisted Differentiation Between Sludge and Organized Thrombus to Guide Left Atrial Appendage Occlusion
Sandeep K. Goyal, MD,a Syed Hyder, BS, a Shizhen Liu, MD, P HD, b Mani A. Vannan, MBBS
doi : 10.1016/j.jacep.2022.10.026
Volume 9, Issue 1, January 2023, Pages 111-116
Percutaneous left atrial appendage occlusion (LAAO) is contraindicated in presence of left atrial appendage (LAA) thrombus. It is often difficult to separate LAA sludge from an organized thrombus on transesophageal echocardiography.
Contributions of Atrioventricular Delay Shortening and Ventricular Resynchronization to Hemodynamic Benefits of Biventricular Pacing
Ahran D. Arnold, MBBS, PhD Matthew J. Shun-Shin, BMBCh, PhD Nadine Ali, BMBCh Daniel Keene, MBChB, PhD James P. Howard, MB BChir, PhD Darrel P. Francis, MB BChir, MD *Zachary I. Whinnett, BM, BS, PhD
doi : 10.1016/j.jacep.2022.07.024
Volume 9, Issue 1, January 2023, Pages 117-119
Ventricular Conduction Velocity Following Multimodal Ablation Including Stereotactic Body Radiation Therapy for Refractory Ventricular Tachycardia
John Whitaker, BM, BCh, PhD Jeremy Bredfeldt, PhD Steven E. Williams, MBBS, PhD Pierre Qian, MBBS, PhD David Chang, MD Raymond H. Mak, MD Hubert Cochet, MD, PhD William Sauer, MDPaul C. Zei, MD, PhD *Usha Tedrow, MD, MSc
doi : 10.1016/j.jacep.2022.08.032
Volume 9, Issue 1, January 2023, Pages 119-121
Takotsubo Syndrome Following Catheter Ablation for Atrial Fibrillation: A Single-Center Experience
Sanghamitra Mohanty, MD Carola Gianni, MD, PhD Angel Mayedo, MD Bryan MacDonald, MD Amin Al-Ahmad, MD Mohamed Bassiouny, MD G. Joseph Gallinghouse, MD Rodney Horton, MD John D. Burkhardt, MD *Andrea Natale, MD
doi : 10.1016/j.jacep.2022.08.028
Volume 9, Issue 1, January 2023, Pages 121-123
Cardiac Repolarization in Health and Disease
Christian Krijger Juárez, BS C,a Ahmad S. Amin, MD, PHD, b Joost A. Offerhaus, MD, a Connie R. Bezzina, P HD, a Bastiaan J. Boukens, PHD
doi : 10.1016/j.jacep.2022.09.017
Volume 9, Issue 1, January 2023, Pages 124-138
Abnormal cardiac repolarization is at the basis of life-threatening arrhythmias in various congenital and acquired cardiac diseases. Dysfunction of ion channels involved in repolarization at the cellular level are often the underlying cause of the repolarization abnormality.
Electrical Resynchronization After Left Bundle Branch Pacing
Shunmuga Sundaram Ponnusamy, MD, DM,a Sabari Saravanan, BE,b William Basil, BE, c Pugazhendhi Vijayaraman, MD
doi : 10.1016/j.jacep.2022.09.010
Volume 9, Issue 1, January 2023, Pages 139-141
Interventricular Septal Hematoma With Pericardium Effusion After Left Bundle Branch Pacing Implantation
Xueying Chen, MD, a,b, * Hao Lu, MD,a,b, * Lili Xu, MD, a,b, * Haiyan Chen, MD, a,b Ye Xu, MD, a,b Shikun Xu, MD, a,b Qibing Wang, MD,a,b Juying Qian, MD, a,b Junbo Ge, MD
doi : 10.1016/j.jacep.2022.09.009
Volume 9, Issue 1, January 2023, Pages 142-144
